scientific program

scientific program

SCIENTIFIC PROGRAM

Friday, March 3, 2017

09:00

Registration and Distribution of Materials

11:30-12:45

RIETE/SEMI SYMPOSIUM

Chairs:     Manuel Monreal, Spain

                 Benjamin Brenner, Israel

11:30

Abnormal uterine bleeding during anticoagulant therapy for VTE

Farès Moustafa, France

11:40

Outcome after discontinuing anticoagulation in women with VTE after hormonal therapy

Angeles Blanco, Spain

11:50

Bleeding in women with VTE and thrombophilia

Manolis Papadakis, Greece

12:00

VTE recurrence: correlations with gender and thrombophilia

Inna Tzoran, Israel

12:10

Gender differences in occult cancer after VTE

Luis Jara-Palomares, Spain

12:20

Round-Table Discussion

14:00

 

Opening Remarks

Symposium Chairmen

Ian A. Greer, UK; Benjamin Brenner, Israel; Manuel Monreal, Spain

14:10-15:45

SESSION 1: Cancer and Thrombosis in Women

14:10

Thrombosis, cancer and women’s health: Lessons from RIETE

Manuel Monreal, Spain

14:35

Role of heparanase in cancer and thrombosis

Yona Nadir, Israel

15:00

Update on antithrombotic management guidelines

Dominique Farge, France

15:25

Selected Oral Communications

OC-1a

A prospective study of hemostatic biomarkers to predict early recurrence in high-risk breast cancer women undergoing post-surgical adjuvant systemic therapy

M. Marchetti, G. Masci, C. Verzeroli, C. Giaccherini, L. Celio, B. Merelli, R. Sarmiento, S. Brevi, S. Gamba, V. Milesi, L. Russo, C. J. Tartari, P. Malighetti, D. Spinelli, F. De Braud, R. Labianca, G. Gasparini, A. Santoro, and A. Falanga on behalf of the HYPERCAN investigators (Italy)

OC-1b

A new genetic risk score for predicting venous thromboembolism events in cancer patients receiving chemotherapy

A. Muñoz, I. Ortega, C. Font, V. Pachón, V. Castellón, V. Martínez, M. Salgado, E. Martínez, J. Calzas, J.C. Souto, E. Salas, J.M. Soria Fernández (Spain)

OC-1c

Effects of low and high-dose doxorubicin and paclitaxel on thrombogenicity and tumorigenic characteristics of extracellular vesicles derived from breast cancer cell lines

A. Aharon, A. Rebibo-Sabbah, L. Issman, H. Berkovich, L. Koren, H. Stern, Y. Abboud, Y. Talmon, B. Brenner (Israel)

15:45 – 16:15

Coffee Break & Exhibition Visit

16:15 – 18:00

SESSION 2: Pregnancy Complications

 

16:15

Placental hemostasis and sterile inflammation: New insights into placental vascular disease

Berend Isermann, Germany

16:40

Antiphospholipid antibodies and the risk of pregnancy complications

Jean-Christophe Gris, France

17:05

Anticoagulants to prevent recurrent placenta mediated pregnancy complications: Is it time to put the needles away?

Marc A. Rodger, Canada

17:30

Selected Oral Communications

OC-2a

Novel genes and mutations in patients with recurrent spontaneous abortion

P. Quintero-Ronderos, E. Mercier, MN. Fukuda, D. Vaiman, JC. Gris, P. Laissue - The Collaborative Group on Precision Medicine in Pregnancy-related Diseases (France; Colombia; USA)

OC-2b

Estimating the potential benefit of low-molecular-weight heparin in M2/ANXA5 haplotype carriers with recurrent pregnancy loss: A secondary analysis of the ETHIG II trial

N. Rogenhofer, A. Markoff, A. Wagner, H.-G. Klein, D. Petroff, E. Schleussner for the EThIG II Group and Christian J. Thaler (Germany)

20:00 - 22:00

GET TOGETHER RECEPTION

 

Saturday, March 4, 2017

08:30 – 10:15

SESSION 3: Arterial Thrombosis

08:30

Atherosclerosis, inflammation and coagulation

Lina Badimon, Spain

08:55

Antiphospholipid syndrome

Ricardo Cervera, Spain

09:20

Managing long-term oral anticoagulation in women

Michael Nagler, Switzerland

09:45

Selected Oral Communications

OC-3a

Lifestyle modification increases the take-home baby rate in women with recurrent early miscarriages: A randomised study

S. Hoirisch-Clapauch, M. Constan Werneck Sant’Anna, E. Cinelli Couto Moreira, P. Pontes Frankel, H. Castro Neves, M. Pereira Valle, M. Machado D’Ippolito, (Brazil)

OC-3b

Increased baseline TF activity in women with unexplained pregnancy loss: an additional argument for a basal endothelial dysfunction?

E. Pasquier, P. Van Dreden, A. Rousseau, L. de Saint Martin, D. Mottier, F. Couturaud (France)

OC-3c

Mechanism of thrombin generation in pregnant women

Siti K Ismail, Azim Johari, John R Higgins and Lucy Norris (Ireland; Brunei Darussalam)

10:15 – 10:45

Coffee Break & Exhibition Visit

10:45 – 12:30

SESSION 4: Systemic Syndromes

 

10:45

Impact of haemostatic mechanisms on pathophysiology of preeclampsia

Chris Gardiner, UK

 

11:10

Effect of BMI on hemostasis: Implications for thrombosis in women’s health

Beverly J. Hunt, UK

 

11:35

DIC score in pregnant women

Ofer Erez, Israel

12:00

Selected Oral Communications

OC-4a

Comparison of two diagnostic scores of disseminated intravascular coagulation in pregnant women admitted to the ICU

M. Jonard, AS. Ducloy-Bouthors, F. François (France)

OC-4b

Blood transfusion and postpartum hemorrhage as risk factors for postpartum venous thromboembolism

Lars Thurn, Agneta Wikman, Pelle G Lindqvist (Sweden)

12:30-13:30

LUNCH

13:30 – 15:15

SESSION 5: Acute Coronary Syndromes and Hormonal Impacts on Hemostasis

13:30

Prevention and management of ovarian hyperstimulation syndrome

Scott M. Nelson, UK

13:55

LMWH use in IVF - Biomarkers and benefits

Simon Fishel, UK  

14:20

Does ART influence the use of thromboprophylaxis in pregnancy?

Elvira Grandone, Italy

14:45

Selected Oral Communications

OC-5a

The prevalence of laboratory abnormalities of haemostasis in women with endometriosis: A case-control study

J. Davies, B. Hussein, A. Riddell, O. Rahimy, R. A Kadir (United Kingdom)

OC-5b

Venous Thrombosis in Assisted Reproductive Techniques: findings from RIETE registry

E. Grandone1, M. Villani1, D. Colaizzo1, C. Fernández-Capitán2, J. Del Toro3, V. Rosa4, A. Bura-Riviere5, I. Quere6, P.P. Di Micco7, Á. Blanco-Molina8, M. Monreal9 for the RIETE Investigators (Italy; Spain; France)

15:15 – 15:45

Coffee Break & Exhibition Visit

15:45 – 18:00

Poster Session

20:00

FAREWELL DINNER (optional)

 

Sunday, March 5, 2017

09:00 – 10:45

SESSION 6: Bleeding Disorders

09:00

Menorrhagia - Update on management

Rezan Abdul-Kadir, UK

09:25

Liver disease in pregnancy

Ton Lisman, the Netherlands

09:50

Acquired hemophilia

Gili Kenet, Israel

10:15

Selected Oral Communications

OC-6a

The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: A nationwide inpatient sample (NIS)-based analysis

A.L. Marshall, U. Durani, A. Bartley, A. Ashrani, C. Rose, R.S. Go and R. Pruthi (USA)

OC-6b

Is the risk of bleeding complications related to SSRI dose-dependent? - A cohort study

M. Öndemark, P.G Lindqvist (Sweden)

10:45 – 11:15

Coffee Break & Exhibition Visit

11:15 – 13:00

SESSION 7: Venous Thromboembolism in Women

11:15

The influence of family history and thrombophilia on risk of gestational VTE

Rainer Zotz, Germany

11:40

Pitfalls in the diagnosis of pulmonary embolism in pregnancy  

Liselotte M. van der Pol, the Netherlands

12:05

Risk-adapted management of pulmonary embolism 

Stavros V. Konstantinides, Germany

12:30

Selected Oral Communications

OC-7a

Imaging for the exclusion of pulmonary embolism in pregnancy - A Cochrane Systematic Review of diagnostic test accuracy

T. E van Mens, L. JJ Scheres, P. G de Jong, M. MG Leeflang, M. Nijkeuter, S. Middeldorp (the Netherlands)

OC-7b

Implementation of risk score-guided prophylaxis in over 2000 pregnant women at risk of thrombotic events: Impact on morbidity. A quasi-experimental prospective study

C. Chauleur, JC. Gris, S. Laporte, C. Chapelle, V. Equy, P. Gaucherand, E. Bazan, O. Dupuis, A. Buchmuller, D. Gallot, P. Mismetti, the STRATHEGE Investigators, and the STRATHEGE Group (France)

OC-7c

Case control study of the predictors of pregnancy-induced venous thromboembolism among Saudi pregnant women

M.A. Alsheef, A.M. Alabbad, R.A. Albassam, R.M. Alarfaj, O.A. Alarfaj (Saudi Arabia)

13:00 – 14:00

LUNCH

14:00 – 16:00

SESSION 8: Peri-partum and Neonatal Complications

14:00

Immune thrombocytopenia in pregnancy

Sue Pavord, UK

14:25

Neonatal thrombosis

Monika Stoll, Germany

14:50

Allo-immune thrombocytopenia

Lilach Bonstein, Israel

15:15

Selected Oral Communications

OC-8a

Diagnosis of pulmonary embolism in pregnancy (DiPEP)

Professor B. Hunt on behalf of the DiPEP research team (UK)

OC-8b

Epidemiology of puerperium-associated venous thromboembolism: A population-based study

P. Galambosi, M. Gissler, R. Kaaja, VM. Ulander (Finland)

OC-8c

Hemorrhage risk evaluation during pregnancy and caesarean section in patients with mesenchymal dyplasias

L. Radetskaya, A. Makatsariya

 

16:00

 

Concluding Remarks – Symposium Chairmen